| Literature DB >> 33173252 |
Mohammad Nasir Uddin1, Md Shaharier Amin1, Md Saifur Rahman1, Sonia Khandaker1, Wahhida Shumi2, Md Atiar Rahman3, Sheikh Mahbubur Rahman4.
Abstract
Symmetrical bis-Schiff bases (LH 2) have been synthesized by the condensation of 1,6-hexanediamine (hn) and carbonyl or dicarbonyl. One of the synthesized Schiff bases has been subjected to the molecular docking for the prediction of their potentiality against coronavirus (SARS-CoV-2). Molecular docking revealed that tested Schiff base possessed high binding affinity with the receptor protein of SARS CoV-2 compared with hydroxychloroquine (HCQ). The ADMET analysis showed that ligand is non-carcinogenic and less toxic than standard HCQ. Schiff bases acting as dibasic tetra-dentate ligands formed titanium (IV) complexes of the type [TiL(H2O)2Cl2] or [TiL(H2O)2]Cl2 being coordinated through ONNO donor atoms. Ligands and complexes were characterized by the elemental analysis and physicochemical and spectroscopic data including FTIR, 1H NMR, mass spectra, UV-Visible spectra, molar conductance, and magnetic measurement. Optimized structures obtained from quantum chemical calculations supported the formation of complexes. Antibacterial, antifungal, and anti-oxidant activity assessments have been studied for synthesized ligands and complexes.Entities:
Keywords: anti‐oxidant activity; bis‐Schiff bases; coronavirus (SARS‐CoV‐2); inhibitors; titanium (IV) complexes
Year: 2020 PMID: 33173252 PMCID: PMC7645963 DOI: 10.1002/aoc.6067
Source DB: PubMed Journal: Appl Organomet Chem ISSN: 0268-2605 Impact factor: 4.072
FIGURE 1Schematic presentation of synthesis of a representative ligand, Sal‐hn‐SalH 2
FIGURE 21H NMR spectrum of a representative ligand, Sal‐hn‐SalH 2
FIGURE 3Mass fragmentation pattern of HNP‐hn‐HNPH 2
FIGURE 4FTIR spectrum of a representative complex, [Ti (Sal‐hn‐SalH 2)(H2O)2Cl2]
FIGURE 5The mass spectra of a representative complex, Ti[(HNP‐hn‐HNP)(H2O)2Cl2]
FIGURE 6Molecular formula and geometry of prepared complexes
(a.) Thermodynamic properties of HNP‐hn‐HNPH and Ti[(HNP‐hn‐HNP)Cl2].2H2O obtained by “density functional theory,” (b.) binding affinity, nonbonding interaction, and (c.) pharmacokinetic properties of HNP‐Hn‐HNPH2 and hydroxychloroquine with SARS Cov‐2
| a. Thermodynamic properties | b. Binding affinity, nonbonding interaction | ||||||
| Property | HNP‐hn‐HNP | Ti[(HNP‐hn‐HNP)(H2O)2Cl2] | Name | Binding affinity (kcal/mol) | Residues in contact | Interaction type | Distance (Å) |
| Electronic energy (Hartree) | −652.7109 | −1400.953 | HNP‐hn‐HNPH2 | −6.3 | Gln110 | H | 2.4452 |
| Enthalpy (Hartree) | −652.8021 | −1400.952 | Gln110 | C | 3.0672 | ||
| Gibb's free energy (Hartree) | −653.3249 | −1401.031 | Phe294 | Pp | 3.8712 | ||
| Dipole moment (D) | 1.9703 | 7.309 | Phe294 | Pp | 3.8836 | ||
| 𝜀HOMO (eV) | −8.5669 | −5.2115 | HCQ | −5.8 | Tyr154 | H | 2.47092 |
| 𝜀LUMO (eV) | −0.8640 | −3.3103 | Gln110 | H | 2.80338 | ||
| Gap (El‐Ev) eV | 7.70285 | 1.9012 | Thr111 | H | 2.89271 | ||
| Hardness | 3.8514 | 7.309 | Asp153 | C | 2.43213 | ||
| Softness | 0.2596 | 1.0519 | Gln110 | C | 2.56382 | ||
| Thr111 | C | 2.29355 | |||||
| Arg298 | A | 3.77516 | |||||
| c. Pharmacokinetic parameters | |||||||
| Drug | Blood brain barrier | Human intestinal absorption | P‐glyco protein inhibitor | hERG | Carcinogen | Rat acute toxicity LD50 (mol/kg) | |
| HNP‐hn‐HNPH2 | +(0.6626) | +(0.9282) | NI(0.7147) | SI(0.6178) | NC(0.8182) | 2.2838 | |
| HCQ | +(0.5602) | +(0.9892) | NI(0.7297) | WI(0.6798) | NC(0.8370) | 2.6348 | |
Abbreviations: A, alkyl; C, carbon hydrogen bond; H, conventional hydrogen bond; NC, non‐carcinogen; NI, non‐inhibitor; PA, Pi‐alkyl; WI, weak inhibitor.
FIGURE 7Optimized structure, HOMO, and LUMO of HNP‐hn‐HNPH and Ti[(HNP‐hn‐HNP)(H2O)2Cl2] after DFT calculations
FIGURE 8Fungal activity evaluation of test samples against by pH measurement
FIGURE 9Docked conformations and nonbonding interactions of HNP‐Hn‐HNPH2 and hydroxychloroquine at inhibition bounding site of receptor protein 6LU7
FIGURE 10Molecular docking of HNP‐Hn‐HNPH2 with receptor protein 6LU7.6LU7‐HNP‐Hn‐HNPH2 complex depicting the possible hydrogen bonding and hydrophobic Pi‐Pi interactions with Gln 110 and Phe 294 amino acid residue, respectively
Total phenolic content and total anti‐oxidant capacity of test samples
| Name of test sample | Total phenolic content (mg GAE/g) | Total anti‐oxidant capacity (mg AAE/g) | ||||||
|---|---|---|---|---|---|---|---|---|
| Eq. conc. (μg/ml) | Average conc. | TPC | RSD (%) | Eq. conc. (μg/ml) | Average conc. | TAC | RSD (%) | |
| Ti[(AA‐hn‐AA)(H2O)2]Cl2 | 481.28 | 481.09 ± 0.32 | 300.68 | 0.07 | 4.09 | 3.95 ± 0.24 | 4.74 | 5.98 |
| 481.28 | 4.09 | |||||||
| 480.72 | 3.68 | |||||||
| Ti[(HNP‐hn‐HNP)(H2O)2Cl2] | 276.28 | 275.53 ± 0.85 | 172.21 | 0.31 | 9.55 | 9.25 ± 0.53 | 11.56 | 5.68 |
| 274.60 | 8.64 | |||||||
| 275.72 | 9.55 | |||||||
| Ti[(Sal‐hn‐Sal)(H2O)2Cl2] | 135.17 | 134.80 ± 0.32 | 84.25 | 0.24 | 15.00 | 14.15 ± 0.92 | 16.85 | 6.47 |
| 134.61 | 13.18 | |||||||
| 134.61 | 14.27 | |||||||
| Ti[(HPP‐hn‐HPP)(H2O)2]Cl2 | 559.61 | 559.24 ± 0.31 | 349.53 | 0.56 | 31.36 | 31.06 ± 0.53 | 38.83 | 1.69 |
| 559.06 | 30.45 | |||||||
| 559.06 | 31.36 | |||||||
| HPP‐hn‐HPP | 109.06 | 109.24 ± 0.85 | 68.28 | 0.77 | 27.73 | 27.43 ± 0.53 | 34.29 | 1.92 |
| 108.50 | 26.82 | |||||||
| 110.17 | 27.73 | |||||||
| AA‐hn‐AA | 93.50 | 93.68 ± 0.85 | 58.55 | 0.90 | ||||
| 92.94 | ||||||||
| 94.61 | ||||||||
| HNP‐hn‐HNP | 187.38 | 186.64 ± 1.27 | 116.65 | 0.68 | ||||
| 187.38 | ||||||||
| 185.17 | ||||||||
| Sal‐hn‐Sal | 127.39 | 127.02 ± 1.15 | 79.39 | 0.91 | ||||
| 125.72 | ||||||||
| 127.94 | ||||||||
Abbreviations: TAC, total anti‐oxidant capacity; TPC, total phenolic content determination.